Clinical Trial

A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-120 and AD-120A

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 8, 2025 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Primary endpoint of this study is to evaluate the pharmacokinetic and pharmacodynamic characteristics of AD-120 in healthy subjects.
Trial Details
NCT Number NCT06916130
Lead Sponsor Addpharma Inc.
Conditions Gastroesophageal Reflux Disease (GERD)
Enrollment 48 participants
Start Date 2025-04-21
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-08